Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (10) , 1321-1328
- https://doi.org/10.1038/modpathol.3800456
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotypeThe Journal of Pathology, 2004
- Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseasesLaboratory Investigation, 2004
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Expression of luminal and basal cytokeratins in human breast carcinomaThe Journal of Pathology, 2004
- BRCA1 functions as a breast stem cell regulatorJournal of Medical Genetics, 2004
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Breast cell invasive potential relates to the myoepithelial phenotypeInternational Journal of Cancer, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982